{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:21:46Z","timestamp":1787498506309,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Sleep Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.5664\/jcsm.11770","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:00:23Z","timestamp":1747926023000},"page":"1799-1807","source":"Crossref","is-referenced-by-count":1,"title":["Prescribing controlled substances in sleep medicine clinics: an overview of legal issues and best safety practices"],"prefix":"10.1007","volume":"21","author":[{"given":"Bhanu Prakash","family":"Kolla","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota"},{"name":"Center for Sleep Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Silber","sequence":"additional","affiliation":[{"name":"Center for Sleep Medicine, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Rushlow","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Ramar","sequence":"additional","affiliation":[{"name":"Center for Sleep Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna P.","family":"Mansukhani","sequence":"additional","affiliation":[{"name":"Center for Sleep Medicine, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"e_1_3_2_2_2","volume-title":"Prescription of Controlled Substances: Benefits and Risks.","author":"Preuss CV","year":"2025","unstructured":"Preuss CV , Kalava A , King KC . Prescription of Controlled Substances: Benefits and Risks. Treasure Island, FL : StatPearls Publishing ; 2025 ."},{"key":"e_1_3_2_3_2","volume-title":"Drug Scheduling.","author":"Drug Enforcement Agency","year":"2025","unstructured":"Drug Enforcement Agency . Drug Scheduling. US Drug Enforcement Administration (DEA) . Accessed February 2, 2025 . https:\/\/www.dea.gov\/drug-information\/drug-scheduling"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.11390"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.9328"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6470"},{"key":"e_1_3_2_7_2","volume-title":"International Classification of Sleep Disorders.","author":"American Academy of Sleep Medicine","year":"2023","unstructured":"American Academy of Sleep Medicine . International Classification of Sleep Disorders. 3rd ed , text revision. Darien, IL : American Academy of Sleep Medicine ; 2023 .","edition":"3"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.05.053"},{"key":"e_1_3_2_9_2","volume-title":"Controlled Substances Act.","author":"Ortiz NR","year":"2025","unstructured":"Ortiz NR , Preuss CV . Controlled Substances Act. Treasure Island, FL : StatPearls Publishing ; 2025 ."},{"key":"e_1_3_2_10_2","unstructured":"Center for Disease Control and Prevention . Prescription drug time and dosage limit laws . Accessed February 2 2025 . https:\/\/www.cdc.gov\/phlp\/docs\/menu_prescriptionlimits.pdf"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4808-644"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7103a1"},{"issue":"1","key":"e_1_3_2_13_2","first-page":"25","article-title":"The history of the FSMB","volume":"106","author":"Antalis JS","year":"2017","unstructured":"Antalis JS . The history of the FSMB . J Med Assoc Ga. 2017 ; 106 ( 1 ): 25 .","journal-title":"J Med Assoc Ga."},{"key":"e_1_3_2_14_2","unstructured":"Federation of State Medical Boards . Accessed April 25 2025 . https:\/\/www.fsmb.org\/"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109887"},{"key":"e_1_3_2_16_2","unstructured":"Pew Charitable Trusts . When are prescribers required to use prescription drug monitoring programs? Accessed February 2 2025 . https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/data-visualizations\/2018\/when-are-prescribers-required-to-use-prescription-drug-monitoring-programs"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0661-4"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.12.026"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000206855"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2010.11.002"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2023.107657"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.03.009"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15020262"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1016607"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.11.019"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-014-3010-y"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8062"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.08.033"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.00944.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2013.09.005"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.5788"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/10401230490453743"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118796814"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.82a.14131"},{"key":"e_1_3_2_35_2","unstructured":"Substance Abuse and Mental Health Administration . Methodological summary and definitions . Accessed February 2 2025 . https:\/\/www.samhsa.gov\/data\/report\/2023-methodological-summary-and-definitions"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz007"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02861.x"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230075"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20071038"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27549"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-020-00223-6"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1803910"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2022.2112950"},{"issue":"2","key":"e_1_3_2_44_2","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2014","author":"Mattick RP","year":"2014","unstructured":"Mattick RP , Breen C , Kimber J , Davoli M . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence . Cochrane Database Syst Rev. 2014 ; 2014 ( 2 ): CD002207 .","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51856"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1177\/29767342241289008"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-020-00918-z"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000323"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.12.007"},{"issue":"64","key":"e_1_3_2_50_2","first-page":"15595","article-title":"Implementation of the Ryan Haight online pharmacy consumer protection act of 2008. Interim final rule with request for comments","volume":"74","year":"2009","unstructured":"Implementation of the Ryan Haight online pharmacy consumer protection act of 2008. Interim final rule with request for comments . Fed Regist. 2009 ; 74 ( 64 ): 15595 \u2013 15625 .","journal-title":"Fed Regist."},{"key":"e_1_3_2_51_2","unstructured":"Drug Enforcement Administration Department of Justice Substance Abuse and Mental Health Administration and Department of Health and Human Services . Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications . Federal Register. Accessed February 2 2025 . https:\/\/www.federalregister.gov\/documents\/2024\/11\/19\/2024-27018\/third-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled"},{"key":"e_1_3_2_52_2","unstructured":"Center for Medicare and Medicaid Services . CMS Electronic Prescribing for Controlled Substances (EPCS) Program . Accessed February 2 2025 . https:\/\/www.cms.gov\/medicare\/e-health\/eprescribing\/cms-eprescribing-for-controlled-substances-program"},{"key":"e_1_3_2_53_2","unstructured":"Federal Register . Final Rule: Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances Between Pharmacies for Initial Filling . Accessed February 2 2025 . https:\/\/www.govinfo.gov\/content\/pkg\/FR-2023-07-27\/pdf\/2023-15847.pdf"},{"key":"e_1_3_2_54_2","unstructured":"Center for Connected Health Policy . Center for Connected Health Policy . Access April 25 2025 . https:\/\/www.cchpca.org\/"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:06:37Z","timestamp":1770109597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.11770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.5664\/jcsm.11770"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.11770","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}